NLRP3 and early-onset autosomal dominant Alzheimer disease: The chronic activation of NLRP3 has been implicated in a variety of disorders including atherosclerosis, auto-immune disorders (e.g., multiple sclerosis), and Alzheimer’s disease (Eren and Özören, 2019).